BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7421415)

  • 1. The localization of GABA-transaminase in the striato-nigral system.
    Vincent SR; Lehmann J; McGeer EG
    Life Sci; 1980 Aug; 27(7):595-601. PubMed ID: 7421415
    [No Abstract]   [Full Text] [Related]  

  • 2. The histochemical localization of GABA-transaminase in the efferents of the striatum.
    Vincent SR; Kimura H; McGeer EG
    Brain Res; 1981 Oct; 222(1):198-203. PubMed ID: 7296268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interconnection of GABA-ergic neurons in rat extrapyramidal tract: analysis using intracerebral microinjection of kainic acid.
    Kurihara E; Kuriyama K; Yoneda Y
    Exp Neurol; 1980 Apr; 68(1):12-26. PubMed ID: 7363980
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
    Starr M; Kilpatrick I
    Life Sci; 1981 Nov; 29(22):2281-7. PubMed ID: 7321760
    [No Abstract]   [Full Text] [Related]  

  • 5. A striatal source of glutamic acid decarboxylase activity in the substantia nigra.
    Nagy JI; Fibiger HC
    Brain Res; 1980 Apr; 187(1):237-42. PubMed ID: 7357470
    [No Abstract]   [Full Text] [Related]  

  • 6. GABAergic and cholinergic indices in various regions of rat brain after intracerebral injections of folic acid.
    McGeer PL; McGeer EG; Nagai T
    Brain Res; 1983 Jan; 260(1):107-16. PubMed ID: 6824947
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathway.
    Vincent SR; Nagy JI; Fibiger HC
    Brain Res; 1978 Mar; 143(1):168-73. PubMed ID: 24494
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative histochemical measurement of GABA-transaminase: method for evaluation of intracerebral lesions produced by excitotoxic agents.
    Gale K; Sarvey C; Stork J; Childs JA; Yalisove BL; Dayhoff RE
    Brain Res; 1984 Jul; 307(1-2):255-62. PubMed ID: 6466995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.
    Saavedra JM; Setler PE; Kebabian JW
    Brain Res; 1978 Aug; 151(2):339-52. PubMed ID: 679013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatonigral and pallidonigral pathways studied by a combination of retrograde horseradish peroxidase tracing and a pharmacohistochemical method for gamma-aminobutyric acid transaminase.
    Araki M; McGeer PL; McGeer EG
    Brain Res; 1985 Apr; 331(1):17-24. PubMed ID: 3986561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine-metabolizing enzyme activity in the nigrostriatal system.
    Francis A; Whittemore R; Jeffery DR; Pearce LB; Roth JA
    Biochem Pharmacol; 1987 Jul; 36(13):2229-31. PubMed ID: 3111478
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitors of GABA metabolism: implications for Huntington's disease.
    Schwarcz R; Bennett JP; Coyle JT
    Ann Neurol; 1977 Oct; 2(4):299-303. PubMed ID: 152600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum.
    Oertel WH; Schmechel DE; Brownstein MJ; Tappaz ML; Ransom DH; Kopin IJ
    J Histochem Cytochem; 1981 Aug; 29(8):977-80. PubMed ID: 7024401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex difference in the turnover of GABA in the rat substantia nigra.
    Manev H; Pericić D
    J Neural Transm; 1987; 70(3-4):321-8. PubMed ID: 3681288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA receptor binding in rat striatum: localization and effects of denervation.
    Campochiaro P; Schwarcz R; Coyle JT
    Brain Res; 1977 Nov; 136(3):501-11. PubMed ID: 922498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum.
    Spano PF; Trabucchi M; Di Chiara G
    Science; 1977 Jun; 196(4296):1343-5. PubMed ID: 17159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: properties and localization in dopaminergic neurons.
    Lehmann J; Fibiger HC
    J Neurochem; 1978 Mar; 30(3):615-24. PubMed ID: 681936
    [No Abstract]   [Full Text] [Related]  

  • 19. Presynaptic localization of substance P degradative enzymes(s) in rat substantia nigra.
    Quik M; Emson PC
    Neurosci Lett; 1979 Dec; 15(2-3):217-22. PubMed ID: 93730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA depletion and GABA-transaminase activity increase after intraventricular 6-hydroxydopamine.
    Nistico G; Di Giorgio RM; Rotiroti D; Macaione S
    Biochem Pharmacol; 1979 Oct; 28(19):3030-2. PubMed ID: 518700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.